Diabetes
More Americans will only have to pay $35 a month for insulin in 2024
Managing diabetes will be a less expensive proposition for more Americans in 2024.
Jan 2, 2024
0
9
News tagged with novo nordisk
Diseases, Conditions, Syndromes
Post-COVID-19 brain health impaired versus healthy controls
Brain health after COVID-19 is impaired, but no more than that seen for patients hospitalized for other medical conditions of similar severity, according to a study published online Dec. 28 in JAMA Network Open.
Dec 29, 2023
0
0
Medications
FDA warns of counterfeit ozempic
The U.S. Food and Drug Administration has uncovered counterfeit Ozempic shots in the legitimate U.S. drug supply chain, and is warning patients to be on their guard.
Dec 22, 2023
0
1
Medications
The new generation of weight-loss drugs
Wegovy, Mounjaro, Ozempic... These new drugs drawing such intense attention have raised the hopes of millions around the world suffering from diabetes or obesity. But what are they, how are they used and who makes them?
Dec 4, 2023
0
0
Medications
Chasing weight loss dream, many in US seek Ozempic alternatives
Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.
Dec 4, 2023
0
0
Medications
Pfizer to rethink weight loss pill after high side effect rate
US drugmaker Pfizer on Friday said it would end a clinical trial of its developmental weight loss pill after high side effect rates caused most participants to stop using it.
Dec 1, 2023
0
0
Medications
Novo Nordisk spends big in France to expand obesity drug capacity
Danish pharmaceutical giant Novo Nordisk on Thursday announced a major investment in a French production site to expand capacity including for a blockbuster anti-obesity drug.
Nov 23, 2023
0
1
Medications
Big Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity rates
Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world's biggest drug developers are tapping into the growing treatment market.
Nov 16, 2023
0
0
Diseases, Conditions, Syndromes
Wegovy cuts heart risks by 20% in large trial
In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.
Nov 13, 2023
0
0
Overweight & Obesity
Novo Nordisk invests $6 bn to boost anti-obesity drug output
Danish drugmaker Novo Nordisk said Friday it would invest 42 billion kroner ($6 billion) to expand manufacturing facilities in efforts to meet massive demand for its anti-diabetes and anti-obesity treatments.
Nov 10, 2023
0
0
